Market Overview

Vetr Crowd Calls 'Sell' On EXAS After Strong Earnings Report

Share:

The Vetr crowd on Friday downgraded its rating for EXACT Sciences Corporation (NASDAQ: EXAS) from 5 stars (Strong Buy), issued 617 days ago, to 2.5 stars (Sell). Crowd sentiment at the time of the downgrade was mostly cautious, with 87 percent of Vetr user ratings bearish.

Share price in the cancer diagnostic company jumped by 25 percent Thursday following a large earnings beat which showed the company posting quarterly revenue nearly 30 percent above estimates. The stock broke the $30 level and was hovering just below $31 midday Friday.

Learn how crowdsourced ratings could help you time the market.

Currently, the average analyst target price for EXACT is $23.23. Less than 2 percent of Vetr users are holding EXAS in their watch lists.

Latest Ratings for EXAS

DateFirmActionFromTo
Apr 2020StifelMaintainsBuy
Apr 2020Evercore ISI GroupInitiates Coverage OnOutperform
Jan 2020CitigroupInitiates Coverage OnBuy

View More Analyst Ratings for EXAS
View the Latest Analyst Ratings

 

Related Articles (EXAS)

View Comments and Join the Discussion!

Posted-In: VetrDowngrades Health Care Price Target Crowdsourcing Analyst Ratings

Latest Ratings

StockFirmActionPT
PECFRAMaintains8.0
HUNCFRAUpgrades16.0
CCCFRADowngrades11.0
VOYAPiper SandlerMaintains58.0
PRUPiper SandlerMaintains64.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com